Singapore: University College London (UCL) and Japanese pharmaceutical company Eisai, have entered into a new agreement to establish a Therapeutic Innovation Group (TIG) that will comprise researchers from both organisations working together to investigate radical new ways of treating neurological diseases such as Alzheimer's, Parkinson's and other related disorders.